Initial Prostate Cancer Diagnosis:
Metastatic
(Hormone Sensitive)
Patients with an initial diagnosis of cancer spread to distant parts of the body – metastatic (Stage 4B); Any PSA, Gleason/Grade Group
Treatment Options
- Androgen Deprivation Therapy (ADT) alone
- ADT +
– Docetaxel (Taxotere)
– Abiraterone (Zytiga)
– Apalutamide (Erleada)
– Enzalutamide (Xtandi)
– External Beam Radiation Therapy (EBRT) to primary tumor
– Fine-particle Abiraterone (Yonsa) - Clinical Trial
Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Prostate Cancer Version 4.2023
© National Comprehensive Cancer Network, Inc. 2022. All rights reserved. The complete and current version of the guideline is available at NCCN.org.
IMPORTANT:
This information is provided for educational purposes only to support patients in understanding and discussing appropriate treatment options with their doctors. Included is information from treatment guidelines for doctors and other sources. However, this information should not be considered as patient treatment guidelines or recommendations, but as educational materials only. Patients should discuss treatments identified herein with their doctors to understand the risks and benefits of each based on their personal diagnosis. Treatment decisions should only be made between the patient and his doctor.